DNDT

DND Technologies, Inc. Stock Price

OTCPK:DNDT Community·US$1.9m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

DNDT Share Price Performance

US$0.064
0.01 (22.52%)
US$0.064
0.01 (22.52%)
Price US$0.064

DNDT Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Low risk with weak fundamentals.

3 Risks
0 Rewards

DND Technologies, Inc. Key Details

US$0

Revenue

US$0

Cost of Revenue

US$0

Gross Profit

US$26.2k

Other Expenses

-US$26.2k

Earnings

Last Reported Earnings
Dec 31, 2009
Next Reporting Earnings
n/a
0
0%
0%
0%
View Full Analysis

About DNDT

Founded
1997
Employees
n/a
CEO
David Hong
Website
n/a

DND Technologies, Inc., a holding company, produces and sells various specialty balms. It also manufactures and distributes pharmaceutical products, including Bioassaygen Gel to reduce wrinkles and promote natural skin re-genesis; Bioassaygen Cosmetic Mask for vanity applications; Bioassaygen Bio-Skin, a skin replacement bandage; and Bioassaygen Delivery Gel that accelerates natural skin re-genesis. The company distributes its products through wholesale, retail, and Internet. DND Technologies, Inc. was founded in 1997 and is based in New York, New York.

Recent DNDT News & Updates

No updates

Recent updates

No updates